Disease Markers

Table of Contents: 2023

  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9792838
  • - Retraction

Retracted: Neurotransmitters and Electrophysiological Changes Might Work as Biomarkers for Diagnosing Affective Disorders

Disease Markers
  • Disease Markers -
  • Special Issue
  • Volume 2023
  • - Article ID 9949047
  • - Review Article

Meta-Analysis of Assessment of Total Oxidative Stress and Total Antioxidant Capacity in Patients with Periodontitis

Khadijah Mohideen | Krithika Chandrasekaran | ... | Snehashish Ghosh
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9894804
  • - Retraction

Retracted: Bioinformatics Analysis Identifies ASCL1 as the Key Transcription Factor in Hepatocellular Carcinoma Progression

Disease Markers
  • Disease Markers -
  • Special Issue
  • Volume 2023
  • - Article ID 2097012
  • - Review Article

Insights into the Role of Galectin-3 as a Diagnostic and Prognostic Biomarker of Atrial Fibrillation

Yasmin Mohtasham Kia | Alessandro Cannavo | ... | Amir Hossein Behnoush
  • Disease Markers -
  • Special Issue
  • Volume 2023
  • - Article ID 9672158
  • - Research Article

Correlation Analysis of Prognostic Gene Expression, Tumor Microenvironment, and Tumor-Infiltrating Immune Cells in Ovarian Cancer

Qing Li | Zongjing Yang | ... | Jinghui Zheng
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9896249
  • - Retraction

Retracted: Expression Profile and Prognostic Values of CDH Family Members in Lung Adenocarcinoma

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9851083
  • - Retraction

Retracted: Qing Zao Fang (QZF) Alleviates the Inflammatory Microenvironment of the Submandibular Gland in Sjögren’s Syndrome Based on the PI3K/Akt/HIF-1α/VEGF Signaling Pathway

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9830426
  • - Retraction

Retracted: CBR3-AS1 Accelerates the Malignant Proliferation of Gestational Choriocarcinoma Cells by Stabilizing SETD4

Disease Markers
  • Disease Markers -
  • Special Issue
  • Volume 2023
  • - Article ID 6978234
  • - Research Article

hsa_circ_0129047 Upregulates LYVE1 to Inhibit Hepatocellular Carcinoma Progression by Sponging miR-492

Zhenzhen Feng | Jiyuan Wu
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9760539
  • - Retraction

Retracted: The Choice of Anesthetic Drugs in Outpatient Hysteroscopic Surgery: A Systematic Review and Network Meta-Analysis

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9897025
  • - Retraction

Retracted: Identification of Key Biomarkers and Immune Infiltration in Liver Tissue after Bariatric Surgery

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9836354
  • - Retraction

Retracted: Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients—An Integrated Bioinformatics Approach

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9819720
  • - Retraction

Retracted: Effect of Wrist Dorsiflexion/Palmar Flexion on Median Nerve Deviation and Cross-Sectional Area in Patients with Carpal Tunnel Syndrome

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9823208
  • - Retraction

Retracted: To Explore the Haemostatic Effect of Compression Haemostasis using an Ultrasonic Probe under the Guidance of Ultrasound after Radial Artery Puncture

Disease Markers
  • Disease Markers -
  • Special Issue
  • - Volume 2023
  • - Article ID 9849123
  • - Retraction

Retracted: Peptide ARHGEF9 Inhibits Glioma Progression via PI3K/AKT/mTOR Pathway

Disease Markers
Disease Markers
 Journal metrics
See full report
Acceptance rate6%
Submission to final decision131 days
Acceptance to publication42 days
CiteScore3.700
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.